NanoString Technologies (BMV:NSTG *) - Aktienkurs, Nachrichten und Analyse

This company listing is no longer active

This company may still be operating, however this listing is no longer active. Find out why through their latest events.

NSTG * Aktienübersicht

Develops, manufactures, and sells technology for scientific and clinical information in the fields of genomics and proteomics in the Americas, Europe, the Middle East, and the Asia Pacific.

Über das Unternehmen

NSTG * grundlegende Analyse
Schneeflocken-Punktzahl
Bewertung	4/6
Künftiges Wachstum	1/6
Vergangene Leistung	0/6
Finanzielle Gesundheit	0/6
Dividenden	0/6

Belohnungen

89.1% unter unserer Schätzung des beizulegenden Zeitwerts gehandelt

Prognostiziertes jährliches Umsatzwachstum 16.2%

Risikoanalyse

Negatives Eigenkapital

Aktien sind hochgradig illiquide

Hat keine nennenswerte Marktkapitalisierung (MX$38M)

Die Aktionäre wurden im vergangenen Jahr verwässert

+ 2 mehr Risiken

NS Wind Down Co., Inc. Wettbewerber

DNA Chip Research

TSE:2397

JP¥5.0b

Cryosite

ASX:CTE

AU$43.0m

Magle Chemoswed Holding

OM:MAGLE

SEK 644.1m

Hyundai ADM Bio

KOSDAQ:A187660

₩78.7b

Preisentwicklung & Leistung

Übersicht über alle Höchststände, Veränderungen und Kursrückgänge für NanoString Technologies
Historische Aktienkurse
Aktueller Aktienkurs	US$29.32
52-Wochen-Hoch	US$233.89
52-Wochen-Tief	US$29.32
Beta	1.32
11 Monat Veränderung	0%
3 Monate Veränderung	n/a
1 Jahr Veränderung	n/a
33 Jahre Veränderung	n/a
5 Jahre Veränderung	n/a
Veränderung seit IPO	-96.72%

Aktuelle Nachrichten und Updates

Recent updates

Aktionärsrenditen

	NSTG *	MX Life Sciences	MX Markt
7D	0%	0%	0%
1Y	n/a	0%	0%

Rendite im Vergleich zur Industrie: Unzureichende Daten, um festzustellen, wie NSTG * im Vergleich zur Branche MX Life Sciences abschneidet.

Rendite vs. Markt: Unzureichende Daten, um festzustellen, wie NSTG * im Vergleich zum MX Markt abgeschnitten hat.

Preisvolatilität

Is NSTG *'s price volatile compared to industry and market?
NSTG * volatility
NSTG * Average Weekly Movement	n/a
Life Sciences Industry Average Movement	0%
Market Average Movement	0%
10% most volatile stocks in MX Market	0%
10% least volatile stocks in MX Market	0%

Stabiler Aktienkurs: NSTG * hatte in den letzten 3 Monaten keine nennenswerte Preisvolatilität.

Volatilität im Zeitverlauf: Unzureichende Daten, um die Volatilitätsveränderung von NSTG * im vergangenen Jahr zu bestimmen.

Über das Unternehmen

Gegründet	Mitarbeiter	CEO	Website
2003	550	Brad Gray	www.nanostring.com

NS Wind Down Co., Inc.'s Grundlagenzusammenfassung

Wie verhalten sich die Erträge und Einnahmen von NanoString Technologies im Vergleich zum Marktanteil des Unternehmens?
NSTG * grundlegende Statistiken
Marktanteil	Mex$652.58m
Gewinn(TTM)	-Mex$2.83b
Umsatz(TTM)	Mex$2.76b

0.2x

Kurs-Umsatz-Verhältnis

-0.2x

Kurs-Gewinn-Verhältnis

Ist NSTG * zu teuer?

Siehe Fair Value und Bewertungsanalyse

Erträge & Einnahmen

Wichtige Rentabilitätsstatistiken aus dem letzten Ergebnisbericht (TTM)
NSTG * Gewinn- und Verlustrechnung (TTM)
Einnahmen	US$162.47m
Kosten der Einnahmen	US$104.44m
Bruttogewinn	US$58.04m
Sonstige Ausgaben	US$224.47m
Umsatz	-US$166.43m

Zuletzt gemeldete Gewinne

Sep 30, 2023

Datum des nächsten Gewinnberichts

k.A.

Gewinn per Aktie (EPS)	-3.46
Bruttomarge	35.72%
Nettogewinnspanne	-102.44%
Schulden/Eigenkapital-Verhältnis	-450.4%

Wie hat sich NSTG * auf lange Sicht entwickelt?

Historische Performance und Vergleiche

This company listing is no longer active

NSTG * Aktienübersicht

Belohnungen

Risikoanalyse

NS Wind Down Co., Inc. Wettbewerber

TSE:2397

JP¥5.0b

ASX:CTE

AU$43.0m

OM:MAGLE

SEK 644.1m

KOSDAQ:A187660

₩78.7b

Preisentwicklung & Leistung

Aktuelle Nachrichten und Updates

NS Wind Down Co. Files Form 15

NS Wind Down Co., Inc. Emerged from Bankruptcy

First Amended Disclosure Statement Approved for NanoString Technologies, Inc.

NanoString Technologies, Inc. announced delayed 10-Q filing

Bruker Corporation (NasdaqGS:BRKR) completed the acquisition of Substantially all assets from NanoString Technologies, Inc. (OTCPK:NSTG.Q), NanoString Technologies Germany GmbH, Nanostring Technologies International, Inc. and NanoString Technologies Netherlands B.V.

Recent updates

NS Wind Down Co. Files Form 15

NS Wind Down Co., Inc. Emerged from Bankruptcy

First Amended Disclosure Statement Approved for NanoString Technologies, Inc.

NanoString Technologies, Inc. announced delayed 10-Q filing

Bruker Corporation (NasdaqGS:BRKR) completed the acquisition of Substantially all assets from NanoString Technologies, Inc. (OTCPK:NSTG.Q), NanoString Technologies Germany GmbH, Nanostring Technologies International, Inc. and NanoString Technologies Netherlands B.V.

The Nasdaq Stock Market to Delist the Common Stock of Nanostring Technologies

NanoString Technologies, Inc. announced delayed annual 10-K filing

Patient Square Capital, LP agreed to acquire Substantially all assets of global business operations from NanoString Technologies, Inc. (OTCPK:NSTG.Q) for approximately $220 million.

NanoString Technologies, Inc.(NasdaqGM:NSTG) dropped from NASDAQ Composite Index

NanoString Technologies, Inc.(NasdaqGM:NSTG) dropped from S&P Global BMI Index

Motion for Joint Administration Approved for NanoString Technologies, Inc.

Motion for Joint Administration Filed by NanoString Technologies, Inc.

NanoString Technologies, Inc. Filed for Bankruptcy

Nanostring Launches the CosMx 6,000 Plex RNA Assay and Showcases Whole Transcriptome Imaging Capability

NanoString Technologies, Inc. Releases the First Public Dataset of the Whole Transcriptome Obtained At True Single-Cell Resolution on the CosMx Spatial Molecular Imager

NanoString Technologies Receives Non-Compliance Notice from Nasdaq

10x Genomics Wins Another Patent Infringement Case Against NanoString Technologies

NanoString Technologies, Inc. Updates Earnings Guidance for the Year 2023

NanoString Technologies, Inc. to Report Q3, 2023 Results on Nov 06, 2023

NanoString Technologies, Inc. Launches the Most Comprehensive Spatial Proteomics Panel Ever Offered

Nanostring Appoints Todd Garland as Chief Commercial Officer

New major risk - Negative shareholders equity

Second quarter 2023 earnings released: US$0.92 loss per share (vs US$0.84 loss in 2Q 2022)

NanoString Technologies, Inc. Reiterates Earnings Guidance for the Full Year 2023

Delaware District Court Permits NanoString Technologies, Inc.'s Counterclaims That 10x Genomics and Harvard Violated the Antitrust Laws

NanoString Technologies, Inc. to Report Q2, 2023 Results on Aug 03, 2023

10X Genomics, Inc. Files New Patent Litigation Against Nanostring Technologies, Inc. and Vizgen, Inc. in the European Unified Patent Court

10X Genomics Wins Permanent Injunction Against Nanostring's CosMX Products

NanoString Technologies, Inc. Updates Earnings Guidance for the Year 2023

Independent Director recently bought Mex$2.2m worth of stock

Full year 2022 earnings released: US$3.44 loss per share (vs US$2.54 loss in FY 2021)

NanoString Technologies, Inc. to Report Q4, 2022 Results on Feb 28, 2023

NanoString Technologies, Inc. Showcases Ultra High-Plex 6K RNA Single Cell Imaging at the 2023 Advances in Genome Biology and Technology

NanoString Releases Single Cell Spatial Transcriptomics Dataset Highlighting Data Quality of CosMx Spatial Molecular Imager

NanoString Technologies, Inc. Provides Product and Service Revenue Guidance for the Fourth Quarter and Full Year 2022

CEO, President & Director recently bought Mex$9.8m worth of stock

NanoString Technologies, Inc Begins Commercial Shipments of CosMx Spatial Molecular Imager and AtoMx Spatial Informatics Platform

Third quarter 2022 earnings released: US$0.79 loss per share (vs US$0.69 loss in 3Q 2021)

Now 21% undervalued after recent price drop

NanoString Technologies, Inc. to Report Q3, 2022 Results on Nov 07, 2022

Now 30% undervalued

Now 20% undervalued

Now 21% undervalued after recent price drop

Now 20% undervalued

Nanostring Technologies, Inc. Provides Revenue Guidance for 2022

Second quarter 2022 earnings released: US$0.84 loss per share (vs US$0.60 loss in 2Q 2021)

NanoString Technologies, Inc. to Report Q2, 2022 Results on Aug 04, 2022

NanoString Unveils AtoMx Spatial Informatics Portal at the 2022 Advances in Genome Biology and Technology (AGBT) General Meeting

Nanostring Technologies, Inc. Announces Plans to Commercially Unveil the Cosmx™ Spatial Molecular Imager

NanoString Technologies, Inc. Launches Integrated Informatics to Facilitate Spatial Biology Research Using Next Generation Sequencing

NanoString Technologies, Inc. Announces Resignation of Robert Hershberg from the Board

NanoString Technologies, Inc. Launches New nCounter Pro Analysis System

NanoString Technologies, Inc. Announces Release of a Fully Automated GeoMx RNA Protocol on BOND RX Research Staining Systems

NanoString Technologies, Inc. to Report Q4, 2021 Results on Mar 01, 2022

Nanostring Technologies, Inc. Provides Earnings Guidance for the Fourth Quarter and Full Year of 2021

Aktionärsrenditen

Preisvolatilität

Über das Unternehmen

NS Wind Down Co., Inc.'s Grundlagenzusammenfassung

Erträge & Einnahmen